IgAN/FSGS Monitoring Program | Q2 2026
This educational material is in development by independent expert faculty. Support for this activity is being sought through unrestricted educational grants. If supported, supporters will have no role in faculty selection, content development, conclusions, or dissemination.
Status: In development; support not yet awarded.
Areas of alignment and key monitoring principles from an independent educational program on practical interpretation of longitudinal monitoring in IgA nephropathy (IgAN) and focal segmental glomerulosclerosis (FSGS).
Focus: distinguishing meaningful change from expected variability in monitoring inputs, and defining evaluation-only decision points. This material does not provide treatment recommendations.
Content forthcoming
Expected ~7 days post-session
Monitoring Cadence Map + Evaluation Decision Points (~30-day)